MaaT Pharma plans to advance a global Phase 3 trial [...]
MaaT Pharma has published retrospective real-world data from its CHRONOS [...]
The US Food and Drug Administration (FDA) has accepted for [...]
MaaT Pharma has submitted a marketing authorisation application (MAA) to [...]